GlobeNewswire

HPIL HOLDING Creates a Mutually Beneficial Relationship With the World Traditional Okinawa Karate Federation (WTOKF) in 2018 and Beyond

Dela

Company Sponsors and Supports WTOKF Activities Worldwide as Karate Gets Introduced into the Next Summer Olympic Games

 

SANFORD, Mich., March 06, 2018 (GLOBE NEWSWIRE) -- HPIL HOLDING (the "Company") (OTC Pink:HPIL) announced today that through its agreement with the World Traditional Okinawa Karate Federation (WTOKF), the worldwide karate governing body, the Company continues to create a strong and mutually beneficial relationship with the WTOKF through sponsorships and the support of a variety of activities which are WTOKF-related around the world.   

A number of major events are in store during 2018 which include: The INTERNATIONAL KARATE GASSHUKU in Luzern, Switzerland and the EUROPEAN KARATE CHAMPIONSHIP in Rome, Italy 2018 - these activities are sponsored as well by HPIL HOLDING, as WTOKF's Official Sponsor.  In the past, the WTOKF has been responsible for successfully organizing 13 European Championships, 7 World Championships along with annual training sessions, and International Karate Seminars (Gasshuku).

The WTOKF is an internationally recognized world entity with 84 affiliated member countries worldwide, registered officially in 8834 Schindellegi, Etzelblickstrasse 1, Switzerland.

The purpose of the WTOKF is to constantly improve karate, to globally promote the idea of unifying, educational, cultural and humanitarian values of karate, specifically by promoting youth and development programs, to organize our own international competitions, to set rules and regulations and to ensure their enforcement and to monitor, by the WTOKF.

In addition, the WTOKF will also focus on the development of Karate activities and events in each member country in order to increase the number of practitioners and in the end to permanently raise the level of training of each WTOKF member organization.

In all of these Karate activities and events, the WTOKF works with  the support of HPIL HOLDING.

"Based on the existing agreement, we have great development plans and joint projects for the future," said Hanshi Ionel Bara, President of the World Traditional Okinawa Karate Federation. "We consider this collaboration beneficial to both parties, as we continue to move forward with our events and other activities in 2018, we are grateful for the support and sponsorship of HPIL HOLDING as Official Sponsor of the World Traditional Okinawa Karate Federation (WTOKF)."

Bara continued, "Our collaboration with HPIL HOLDING has been fruitful since its inception, thanks especially to HPIL's Chairman and CEO, Nitin Amersey, whose many years of experience in corporate management, international trade &  marketing and brand creation  have been a vital part of the success of the WTOKF."

Bara said the WTOKF is counting on all Karate organizations and federations around the world and of all practitioners of martial arts, to finally realize the dream of all karateka, for karate to be recognized as an Olympic game in the upcoming 2020 Summer Olympics being held in Tokyo, Japan.

HPIL has entered into a licensing agreement in the US market for use of the WTOKF logo and brand and is seeking licensees worldwide for karate and other apparel and products.

The web site for the WTOKF is https://wtokf.org/

HPIL HOLDING (http://HPILHOLDING.COM) is a holding company listed on OTC Markets.

Safe Harbor / Forward-Looking Statements:

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimate," "expect," "plan," "potential," "seek," and "intend," among others. These forward-looking statements are based on the Company's current expectations and actual results could differ materially. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, substantial competition; our possible need for financing; uncertainties of technological changes; and dependence upon third parties. The Company does not undertake an obligation to update or revise any forward-looking statement. All of the Company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements. The information set forth herein speaks only as of the date hereof.

HPIL HOLDING

For more information, please contact: 

Mr. Peter Nicosia
Tel:  +1(248)750-1015

Email: info@hpilholding.com
Source: HPIL HOLDING

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/f221a1ee-781d-4967-b34a-7a602ff06ebf




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: HPIL HOLDING via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Stillfront Group rekryterar ansvarig för M&A19.12.2018 12:07Pressmeddelande

PRESSMEDDELANDE 19 december, 2018 Stillfront Group rekryterar ansvarig för M&A Stillfront Group, en marknadsledare inom 'free to play' online strategispel, annonserar idag att Marina Andersson har utsetts till ansvarig för M&A och kommer att ingå i koncernledningen. Marina har närmare tjugo års erfarenhet från investment banking och M&A. Hon har omfattande erfarenhet inom strategisk och finansiell rådgivning, affärsgenerering, projektledning inom förvärv och försäljningar av företag, finansiell analys, due diligence, samt företagsvärdering. Tidigare positioner inkluderar: Director, Deloitte's Corporate Finance Advisory team, Director, ICECAPITAL Securities, Associate Partner och Investment Manager, Deseven, samt M&A Analytiker på Carnegie. Marina har två magister-examen från Stockholms universitet och Russian Herzen State Pedagogical University. "Förvärv är en viktig del av Stillfronts affärsstrategi och vi är mycket glada att rekrytera Marina Andersson. Marinas breda erfarenhet och pr

Stillfront Group announces Head of M&A19.12.2018 12:07Pressmeddelande

PRESS RELEASE December 19, 2018 Stillfront Group announces Head of M&A Stillfront Group, a market leader in 'free to play' online strategy games, today announces that Marina Andersson has been appointed as Head of M&A and will be part of the Group's management team. Marina has close to 20 years track record of investment banking and M&A. She has extensive competence within strategic and financial advisory, deal generation, buy and sell side M&A project management, financial analysis, due diligence and company valuation. Former positions include: Director at Deloitte's Corporate Finance Advisory team, Director at ICECAPITAL Securities, Associate Partner and Investment Manager at Deseven, M&A Analyst at Carnegie. She holds two Master degrees from Stockholm University and Russian Herzen State Pedagogical University. "Acquisitions are a crucial part of Stillfront's business strategy and we are very pleased with the appointment of Marina Andersson. Marina's breadth of experience and profess

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum